GWS
REGN icon

Glassman Wealth Services’s Regeneron Pharmaceuticals REGN Stock Holding History

Glassman Wealth Services’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-130
Closed -$114K – 1441
2023
Q4 		$114K Buy
130
+3
+2% +$2.47K 0.02% 273
2023
Q3 		$105K Sell
127
-1
-0.8% -$786 0.02% 268
2023
Q2 		$92K Buy
128
+4
+3% +$3.08K 0.01% 277
2023
Q1 		$102K Buy
124
+7
+6% +$5.28K 0.02% 264
2022
Q4 		$84.4K Buy
117
+8
+7% +$5.9K 0.02% 298
2022
Q3 		$75K Buy
109
+9
+9% +$5.67K 0.02% 300
2022
Q2 		$59K Sell
100
-2
-2% -$1.3K 0.01% 354
2022
Q1 		$71K Buy
102
+25
+32% +$15.8K 0.01% 325
2021
Q4 		$49K Buy
77
+33
+75% +$20.3K 0.01% 378
2021
Q3 		$27K Buy
44
+8
+22% +$4.97K 0.01% 506
2021
Q2 		$20K Buy
36
+9
+33% +$4.56K ﹤0.01% 574
2021
Q1 		$13K Hold
27
– – ﹤0.01% 652
2020
Q4 		$13K Hold
27
– – ﹤0.01% 652
2020
Q3 		$15K Buy
27
+3
+13% +$1.82K ﹤0.01% 517
2020
Q2 		$15K Sell
24
-2
-8% -$1.14K ﹤0.01% 427
2020
Q1 		$13K Buy
26
+16
+160% +$6.6K 0.01% 401
2019
Q4 		$4K Sell
10
-8
-44% -$2.69K ﹤0.01% 631
2019
Q3 		$5K Buy
18
+6
+50% +$1.77K ﹤0.01% 540
2019
Q2 		$4K Sell
12
-15
-56% -$4.99K ﹤0.01% 600
2019
Q1 		$11K Buy
27
+20
+286% +$8.24K ﹤0.01% 440
2018
Q4 		$3K Hold
7
– – ﹤0.01% 504
2018
Q3 		$3K Hold
7
– – ﹤0.01% 552
2018
Q2 		$2K Buy
7
+1
+17% +$313 ﹤0.01% 580
2018
Q1 		$2K Buy
6
+1
+20% +$348 ﹤0.01% 552
2017
Q4 		$2K Sell
5
-3
-38% -$1.22K ﹤0.01% 509
2017
Q3 		$4K Buy
8
+3
+60% +$1.43K ﹤0.01% 374
2017
Q2 		$2K Hold
5
– – ﹤0.01% 423
2017
Q1 		$2K Sell
5
-1
-17% -$371 ﹤0.01% 455
2016
Q4 		$2K Buy
+6
New +$2.28K ﹤0.01% 516

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Glassman Wealth Services's REGN Position: Q1 2024 in Review

Glassman Wealth Services sold out of Regeneron Pharmaceuticals (REGN) in Q1 2024, closing a stake of 130 shares — an estimated $114K sold.

Glassman Wealth Services first reported a position in REGN in Q4 2016 and held it in 29 quarters. The position peaked at $114K in Q4 2023. 1,312 funds tracked by Wall St. Rank hold REGN as of Q1 2024.

  • Glassman Wealth Services reported no remaining Regeneron Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • Glassman Wealth Services sold 130 Regeneron Pharmaceuticals shares in Q1 2024, an estimated $114K.
  • Glassman Wealth Services first reported a position in Regeneron Pharmaceuticals in Q4 2016 and held it in 29 quarters.
  • Glassman Wealth Services's Regeneron Pharmaceuticals position peaked at $114K in Q4 2023.
  • 1,312 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2024.

Based on Glassman Wealth Services's 13F filing for Q1 2024, filed 3 May 2024.